Login
$PMA
$1.27 +$0.00 (0.0%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Mar 31, 2024
Assets
Current assets
Cash and cash equivalents
Accounts receivable, net (Note 3)
Contract assets (Note 4)
Deposits, prepayments and other assets (Note 5)
Total current assets
Non-current assets
Property and equipment, net (Note 6)
Finance lease right of use assets
Life insurance policy, cash surrender value
Operating lease right-of-use assets, net (Note 7)
Life insurance policy, cash surrender value (Note 2)
Contract assets (Note 4)
Deferred offering costs
Deferred tax assets (Note 12)
Deposits, prepayments and other assets (Note 5)
Total non-current assets
Total assets
Current liabilities
Accounts payable (Note 8)
Bank and other borrowings (Note 10)
Finance lease liabilities, current portion (Note 7)
Operating lease liabilities, current portion (Note 7)
Accrued expenses and other current liabilities (Note 9)
Amount due to a related party (Note 14)
Income tax payable
Total current liabilities
Non-current liabilities
Bank and other borrowings (Note 10)
Finance lease liabilities, net of current portion (Note 7)
Deferred tax liabilities (Note 12)
Operating lease liabilities, net of current portion (Note 7)
Total non-current liabilities
Total liabilities
Shareholders’ (deficit) equity
Ordinary shares, 100,000,000 shares authorized; USD0.0005 par value, 12,975,000 shares issued and outstanding, as of March 31, 2026 and 2025 (Note 17)
Subscription receivable
Additional paid in capital
Accumulated deficit
Total shareholders’ (deficit) equity
Total liabilities and shareholders’ (deficit) equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support